The Pharma Asia International Exhibition and Conferences serves as Pakistan’s premier pharmaceutical machinery and technology trade show. Pharma Asia event is attracting significant global attention. This flagship event consistently ranks as the largest industry gathering in Pakistan. Manufacturers, innovators, and decision‑makers across pharmaceutical manufacturing and allied sectors connect. The 23rd edition ran from October 20-22, 2026, at the Expo Centre in Karachi, drawing unprecedented participation and business engagement.
Organized by Pharma Asia International Exhibition & Conferences, the exhibition showcased advanced pharma technologies, machinery, and digital solutions. The agenda highlighted industry transformation through modernization, digitalization, and regulatory engagement.
The event featured more than 750 exhibition stalls and over 200 international exhibitors representing at least 10 countries. Prominent global participation from China, Italy, Turkey, Switzerland, and Spain. China hosted the largest international pavilion, underscoring strong multinational interest in Pakistan’s pharmaceutical market.
Review: Pharma Asia 2025 attracted over 27,000 pharmaceutical professionals, including manufacturers, exporters, pharmacists, researchers, regulatory officials, and foreign delegates eager to engage with cutting‑edge technologies and forge partnerships. The visitor profile ranged from industry executives and trade corporate visitors to academic stakeholders and commercial attaches.
Key topics at the exhibition spanned
- pharmaceutical machinery,
- packaging solutions,
- quality control systems,
- laboratory equipment,
- raw materials.
Expert‑led sessions emphasized industry digitization, technology transfer, and export expansion strategies, reflecting the sector’s ambition to reach a USD 10 billion export target.
Outstanding opportunities emerged in technology acquisition, joint ventures, and market expansion across South Asia, the Middle East, and Central Asia. Exhibitors and attendees identified strong prospects for investment facilitation, capacity building, and strategic partnerships with local and foreign stakeholders.
Overall, Pharma Asia remains a catalyst for growth in pharmaceutical machinery and technology, offering a focused environment for networking, business development, and innovation in one of South Asia’s fastest‑growing healthcare markets.
